Table:
begin	end	state
1	19	cytoplasmic
20	38	transmembrane
39	45	non-cytoplasmic
46	68	transmembrane
69	79	cytoplasmic
80	98	transmembrane
99	103	non-cytoplasmic
104	125	transmembrane
126	145	cytoplasmic
146	168	transmembrane
169	181	non-cytoplasmic
182	203	transmembrane
204	232	cytoplasmic
233	253	transmembrane
254	271	non-cytoplasmic
272	291	transmembrane
292	302	cytoplasmic
303	322	transmembrane
323	444	non-cytoplasmic
445	468	transmembrane
469	487	cytoplasmic
488	507	transmembrane
508	512	non-cytoplasmic
513	531	transmembrane
532	543	cytoplasmic

Input:
>Ac3H11_3022
MSPEERKVIFASSLGTVFEWYDFYLYGSLAAIIAKQFFSGLDSGSAFIFALLAFAAGFIV
RPFGAIFFGRLGDMIGRKYTFLVTILIMGLSTFIVGILPTYASIGVAAPIILIVLRLLQG
LALGGEYGGAATYVAEHAPHGRRGAYTAWIQTTATLGLFLSLMVILGTRTIVGEEAFADW
GWRVPFIVSIVLLAISVWIRLAMNESPAFQKMKAEGKTSKAPLKESFGEWKNLKIVILAL
VGLTAGQAVVWYSGQFYALFFLTQALKVDGATANILVAVSLLIGTPFFIVFGSLSDKIGR
KPIILAGCLLAALTYFPVFGALTKAANPALAEAQAKNKVVVVADANECSFQFNPTGTVKF
TSSCDIAKQVLAGASVSYENAPGAAGTPAVIKIGETAITGYSSKGLPADEAKKKDGEFKK
AVADALKAAGYPTKADPARIDKVMVTAILVYLVLLVTMVYGPIAAMLVEMFPTRIRYTSM
SLPYHIGNGWFGGLLPTTAFAIVAQTGNMYNGLWYPIIIAAATVVIGGLFIKETKDVDIY
AND

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server